Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Long Term Debt (2020 - 2023)

MDxHealth has reported Total Long Term Debt over the past 4 years, most recently at $39.1 million for Q4 2023.

  • For Q4 2023, Total Long Term Debt rose 2.99% year-over-year to $39.1 million; the TTM value through Dec 2023 reached $39.1 million, up 2.99%, while the annual FY2023 figure was $39.1 million, 2.99% up from the prior year.
  • Total Long Term Debt was $39.1 million for Q4 2023 at MDxHealth, up from $38.0 million in the prior quarter.
  • Across five years, Total Long Term Debt topped out at $39.1 million in Q4 2023 and bottomed at $10.3 million in Q4 2021.
  • The 4-year median for Total Long Term Debt is $25.2 million (2020), against an average of $24.9 million.
  • Year-over-year, Total Long Term Debt decreased 16.44% in 2021 and then surged 269.88% in 2022.
  • Over 4 years, Total Long Term Debt stood at $12.3 million in 2020, then fell by 16.44% to $10.3 million in 2021, then surged by 269.88% to $38.0 million in 2022, then grew by 2.99% to $39.1 million in 2023.
  • The last three reported values for Total Long Term Debt were $39.1 million (Q4 2023), $38.0 million (Q4 2022), and $10.3 million (Q4 2021) per Business Quant data.